CJC-1295 in both forms is prohibited by the World Anti-Doping Agency under the category of peptide hormones and growth factors
Australian Therapeutic Goods Administration (TGA) : Banned for injection use
The pathogenic characteristics of OA include synovitis, chondrocyte death, deterioration of the extracellular matrix (ECM), subchondral osteosclerosis, and osteophyte formation [4], resulting in elevated incidence and disability rates [5]
If administered parentally, or if administered concurrently in the presence of an MAO inhibitor, elevated levels of plasma tyramine are taken up by presynaptic neuronal NET transporters which induces the release of norepinephrine
Severe pain, swelling, weakness, numbness, fever, unexplained weight loss, blood in stool, persistent vomiting, chest pain, or neurological symptoms should not be managed through peptides or supplements
If you take L-Carnitine and remain sedentary, the transported fats will not be burned and will simply be stored again